Cargando…
Do rogue antibodies make the difference between mild versus severe COVID-19?
Autor principal: | Flemming, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860153/ https://www.ncbi.nlm.nih.gov/pubmed/33542500 http://dx.doi.org/10.1038/s41577-021-00511-4 |
Ejemplares similares
-
Author Correction: Do rogue antibodies make the difference between mild versus severe COVID-19?
por: Flemming, Alexandra
Publicado: (2021) -
The Making of the Andrea Wave and other Rogues
por: Donelan, Mark A., et al.
Publicado: (2017) -
Dexamethasone restrains neutrophils in severe COVID-19
por: Flemming, Alexandra
Publicado: (2021) -
Poor nasal immunity can lead to severe COVID-19
por: Flemming, Alexandra
Publicado: (2021) -
Do individuals who have recovered from COVID-19 still benefit from being vaccinated?
por: Flemming, Alexandra
Publicado: (2022)